🇺🇸 FDA
Pipeline program

Recombinant human arginase 1 Peg5000

BCT-100-003

Phase 1 small_molecule terminated

Quick answer

Recombinant human arginase 1 Peg5000 for Leukemia is a Phase 1 program (small_molecule) at International Peace Maternity and Child Health Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
International Peace Maternity and Child Health Hospital
Indication
Leukemia
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials